Clinical trial
Fluoxetine to Reduce Intubation and Death After COVID19 Infection
NCT04377308 is registered in ClinicalTrials.gov with University of Toledo Health Science Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluoxetine to Reduce Intubation and Death After COVID19 Infection
- Lead sponsor
- University of Toledo Health Science Campus
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 1, 2020
- Completion date
- April 30, 2021
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, cytokine storm